- Intuitive Surgical (ISRG, Financial) sees a significant 19% revenue boost, reaching $2.25 billion in Q1.
- Analysts forecast a potential 30.36% upside with an average target price of $624.07.
- "Outperform" status maintained with a 2.1 average brokerage recommendation.
Intuitive Surgical (NASDAQ: ISRG) has made waves in the medical tech industry with its impressive first-quarter performance. Reporting a substantial 19% increase in revenue to $2.25 billion, the company attributes this growth to the expanding adoption of both U.S. and international surgical procedures. A pivotal element of Intuitive Surgical's success is the advancement of its da Vinci 5 platform, promising innovative strides in surgical technology. Additionally, the firm has revised its gross margin forecast favorably between 65% and 66.5% for the fiscal year.
Wall Street Analysts Forecast
Delving into market expectations, 26 analysts have projected a one-year price target for Intuitive Surgical Inc. (ISRG, Financial), averaging at $624.07. This projection reveals a potential upside of 30.36% from the current stock price of $478.74, with estimates ranging from a high of $700.00 to a low of $510.00. Investors seeking more detailed forecast information can refer to the Intuitive Surgical Inc (ISRG) Forecast page.
Consolidating the outlook from 33 brokerage firms, Intuitive Surgical Inc. (ISRG, Financial) holds an average brokerage recommendation of 2.1. This figure signifies an "Outperform" rating on a scale where 1 indicates a Strong Buy and 5 suggests a Sell.
Evaluating Valuation Metrics
According to GuruFocus's proprietary estimates, the GF Value for Intuitive Surgical Inc. (ISRG, Financial) stands at $485.45—suggesting a modest upside of 1.4% from the current share price of $478.74. The GF Value is a reflection of the stock's fair trading value based on its historical trading multiples, business growth trajectory, and forecasted performance. For a comprehensive analysis, investors can visit the Intuitive Surgical Inc (ISRG) Summary page.
